This pairing is the basis of the pre-combined BPC-157 + TB-500 blend used in combination research, where both peptides are supplied together in a single lyophilized vial
The reports theyve received havent raised concerns about the adequacy of the B12 amount in their supplement (private correspondence with Stephen Walsh in August 2021)
Clinically, BPC-157 is best suited for acute and subacute soft-tissue injuries, including tendon, ligament, muscle, fascia, and periarticular soft-tissue problems
Direct stack-specific clinical trial evidence is limited, and adding compounds increases the safety and quality-control surface area
By Jaimy Lee If the FDA allows the reclassification of seven peptides under consideration, that means compounding pharmacies can legally produce them A group of independent advisers to the FDA is meeting Thursday and Friday to vote whether to reclassify seven peptides, which would broaden their availability in the U.S